Arquivamento definitivo - Art. 33 da LPI
#11.1.1
03/17/2026
RPI 2880
Application data
Number
112024012133Type
Filing
Publication
PCT
US2022081504 The application was abandoned: examination was not requested within the 36 months following the 12/14/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 03/17/2026. We update with every new RPI gazette, published weekly.
Applicants
KINNATE BIOPHARMA INC.
US
Inventors
J. C. (pessoa física)
US
J. T. (pessoa física)
US
R. K. (pessoa física)
US
T. K. (pessoa física)
US
X. O. (pessoa física)
US
IPC Classification
Priority claims
US
63/290,291 · 12/16/2021
US
63/301,267 · 01/20/2022
US
63/380,049 · 10/18/2022
US
63/386,647 · 12/08/2022
Abstract
INIBIDORES DE MET QUINASE. São fornecidos aqui inibidores de MET receptor tirosina quinase, composições farmacêuticas que compreendem os referidos compostos inibidores, e métodos para utilização dos referidos compostos inibidores de MET quinase para o tratamento de doença.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
03/17/2026
RPI 2880
#11.1
12/23/2025
RPI 2868
#1.3
09/17/2024
RPI 2802
#1.1
06/25/2024
RPI 2790
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.